Gene therapy in Parkinson’s disease

被引：0
作者：
O. Eberhardt
J. B. Schulz
机构：
[1] University of Tübingen,Department of General Neurology, Center of Neurology and Hertie Institute for Clinical Brain Research
来源：
Cell and Tissue Research | 2004年 / 318卷
关键词：
Gene therapy; Parkinson’s disease; Animal models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gene therapy in Parkinson’s disease appears to be at the brink of the clinical study phase. Future gene therapy protocols will be based on a substantial amount of preclinical data regarding the use of ex vivo and in vivo genetic modifications with the help of viral or non-viral vectors. To date, the supplementation of neurotrophic factors and substitution for the dopaminergic deficit have formed the focus of trials to achieve relief in animal models of Parkinson’s disease. Newer approaches include attempts to influence detrimental cell signalling pathways and to inhibit overactive basal ganglia structures. Nevertheless, current models of Parkinson’s disease do not mirror all aspects of the human disease, and important issues with respect to long-term protein expression, choice of target structures and transgenes and safety remain to be solved. Here, we thoroughly review available animal data of gene transfer in models of Parkinson’s disease.
引用
收藏
页码：243 / 260
页数：17
相关论文
共 1033 条
[1]  
Akerud P(2001)Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson’s disease J Neurosci 21 8108-8118
[2]  
Canals JM(1993)Transfer of a foreign gene into the brain using adenovirus vectors Nat Genet 3 224-228
[3]  
Snyder EY(1995)Neural transplantation of cells expressing the anti-apoptotic gene bcl-2 Cell Transplant 4 49-54
[4]  
Arenas E(1998)Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice Neuroscience 85 907-917
[5]  
Akli S(2002)Chaperone suppression of alpha-synuclein toxicity in a Science 295 865-868
[6]  
Caillaud C(2002) model for Parkinson’s disease J Neurosci 22 10302-10312
[7]  
Vigne E(2004)Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic Neuroreport 15 985-990
[8]  
Stratford-Perricaudet LD(1997)-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson’s disease Exp Neurol 144 147-156
[9]  
Poenaru L(2000)Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector Exp Neurol 164 2-14
[10]  
Perricaudet M(1997)Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson’s disease Neuroscience 78 703-713
12345678910